Text

First Episode of ‘StartUp Health NOW’ Features Long-Form Interview with AdhereTech Cofounder Josh Stein

As you know, AdhereTech is a proud member of the StartUp Health GE Entrepreneurship Program.

In a bold move, StartUp Health recently launched a new web series and podcast called ‘StartUp Health Now.’ The first episode features a long-form interview with AdhereTech CEO & Cofounder Josh Stein. Josh and StartUp Health Cofounder Steven Krein discuss their perspectives on entrepreneurship, team-building, and AdhereTech’s path to success.

The interview is long, so we’ll keep this post short: watch it here or download the podcast here.

Text

PharmD Professors Discuss the Value of AdhereTech’s Smart Pill Bottle and the Data It Collects - in Pharmacy Practice News

It’s no secret that medication non-adherence is one of the largest problems in healthcare. As health tech innovators search for new tools to improve adherence, many experts agree that a seamless piece of hardware, like the AdhereTech smart pill bottle, has distinct advantages. Pharmacy Practice News reports:

Kevin Clauson, PharmD, an associate professor of pharmacy practice at Lipscomb University College of Pharmacy in Nashville… suggested that bridge technology is a more promising strategy [to improve medication adherence, compared to smart phone apps.]

Bridge technology starts with something familiar, like a physical pillbox [or pill bottle] and then translates that to a digital solution, he said. 

Dr. Clauson then discusses the specific advantages of AdhereTech:

“[AdhereTech’s] device has a lot of potential to improve medication adherence as it attacks the problem in multiple ways,” Dr. Clauson said. “Also, because it comes in the form of a familiar pill bottle that patients already use, it does not force them to integrate a new device into their lives. Since sensors could actually measure [adherence and] stream the data to the patient, pharmacist or physician, it also offers a potentially useful data stream to help with tailoring therapy and interventions.”

As AdhereTech continues to built out our technology, experts see large value in the data that we collect, including Dr. Lindsey Dayer, PharmD, BCACP, an assistant professor of pharmacy practice at UAMS College of Pharmacy:

One feature that could facilitate this trend [of technology adoption in healthcare] and prove very beneficial, especially for health care providers, is a level of connectivity to the electronic health record, Dr. Dayer said. It would enable providers to better evaluate how and when patients take their medications, and possibly lead to better treatment outcomes, she continued.

Text

Deloitte’s Center for Health Solutions Agrees with the Thesis of AdhereTech CEO Josh Stein’s TED Talk at TEDMED

Sarah Thomas is the director of research for Deloitte’s Center for Health Solutions. She was also lucky enough to attend TEDMED 2014. On Deloitte’s blog, she discusses a trend that she sees in much of the new healthcare technologies:

In thinking about the range of technologies I encountered, they seemed to fall along a spectrum of consumer engagement. Some required little input from consumers while others required extensive interaction… I couldn’t picture myself, much less my mother, taking the time to document all the interactions with the health care system – it just seemed like too much work.

So it was with great interest that I listened to the [TED talk] from Josh Stein, a “serial entrepreneur,” who said something… that really resonated with me. He said that some of the best ideas in the new technologies do not require patients or consumers to become actively engaged. Instead, the technologies take on as much of the job as possible. Josh’s company, AdhereTech, has invented a “smart pill bottle” that uses cell-phone technology to monitor whether patients are taking their medications. And when they forget, the system sends a text or calls to remind the patient to take the medication.

It is such an honor when smart, forward-thinking people like Sarah agree with our vision. She continues:

This presentation made me think that one aspect of mHealth is how much it makes the patient do. In my opinion, the less a technology makes people do, the more likely it will be in successfully getting the information into the hands of those who can use it to realize the potential for the IoT.

That’s exactly right! Sarah also touches on some of the more future-facing aspects of Josh’s TED Talk:

Josh also talked about the Internet of Things (IoT) where things like this smart pill bottle… could help a physician and care team remotely track a patient’s care pattern over time. The overall patient data could then be used to gain new insights on how people respond to therapies. Ultimately, this technology could lay the groundwork for better technology and care.

Text

AdhereTech Advances to the Finals of LIVESTRONG’s Big C Competition

AdhereTech is incredibly honored and humbled to announce that we have made it to the finals of the LIVESTRONG Big C competition! Forbes reports:

This year, LIVESTRONG launched the first annual “Big C Competition,” a global contest to identify the most innovative products and services improving the daily lives of the world’s estimated 32.5 million people living with cancer. 

And more from the official release:

From more than 750 entries from around the world… the final five projects demonstrate a flair for creative solutions, along with business acumen to find solutions to the most common problems those affected by cancer face on a daily basis. The finalists will present their ventures to a panel of seven expert judges on Oct. 17 and the grand prize winner will be revealed at the finale event at the Austin Music Hall.

AdhereTech is so honored to be recognized by two world-renowned organizations, LIVESTRONG and Verb:

We are pleased to introduce you to AdhereTech. This incredible venture makes smart pill bottles for oral chemotherapy to improve medication adherence and patient engagement.

LIVESTRONG’s CEO spoke highly of the five finalists:

“We are blown away by the quality of the final five projects and know that, regardless of the outcome, all five will go on to improve the lives of the 32.5 million cancer patients and survivors worldwide,” said LIVESTRONG Foundation President and CEO Doug Ulman. “While all of the semifinalists’ entries stood out, these five demonstrated an intimate knowledge of the daily challenges faced due to a diagnosis. They all demonstrate creative, realistic and trailblazing solutions for people affected by cancer.”

Of course we’re all very familiar with the LIVESTRONG Foundation. Here’s a quick look at how successful and effective this amazing organization has been since its inception:

The LIVESTRONG Foundation fights to improve the lives of people affected by cancer now. Created in 1997, the Foundation is known for providing free cancer support services and advocating for policies that improve access to care and quality of life. Known for its powerful brand – LIVESTRONG – the Foundation has become a symbol of hope and inspiration around the world. Since its inception, the Foundation has served 2.8 million people affected by the disease and raised more than $580 million to support cancer survivors. One of America’s top non-profit organizations, the Foundation has been recognized by industry leaders including Charity Navigator, the National Health Council and the Better Business Bureau for its excellent governance, high standards and transparency. For more information, visit LIVESTRONG.org.

And here’s a great overview of the finalists from MedCity News.

Text

PM360 Includes AdhereTech in “12 New Tools for Improved Adherence” Report

PM360 is a popular magazine for marketers and decision makers in the pharmaceutical, biotech, and medical device industries. The most recent issue contains an article titled “12 New Tools for Improved Adherence.” AdhereTech is proud to be listed amongst these promising companies.

The article first gives an overall summary of AdhereTech’s product and technology:

AdhereTech’s smart pill bottles are an ideal solution for specialty medications and clinical trials. These FDA-registered Class I medical devices are built with cellular technology and numerous sensors. They work by automatically sending adherence data to AdhereTech’s servers, where analysis occurs in real time. If a dose is missed, AdhereTech’s system immediately reminds the patient via an automated phone call or text message—as well as on-bottle lights and chimes. If the system notices prolonged non-adherence, it can solicit feedback from patients via text or phone call to immediately understand the reasons for non-adherence, and intervene accordingly.

Next, AdhereTech’s unique point of differentiation is discussed:

AdhereTech is taking a unique approach to the issue of medication adherence. This solution focuses on creating a simple and easy patient experience. AdhereTech’s bottles are used just like normal pill bottles, and they require no set up. They connect to the cloud automatically, and the system works equally well for patients with landlines, cell phones or smartphones.

Finally, the article mentions AdhereTech’s plans for the near future:

In early 2015, AdhereTech will be releasing their Generation 2 smart pill bottles, which will work in the same way as their current bottles, but will have the overall size and look of regular pill bottles. AdhereTech is actively seeking additional partners who are interested in their product and technology.